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CASE REPORT
Perioperative glycaemic control 
for preterm infant with transient neonatal 
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Abstract 
Background: Neonatal hyperglycaemia is a rare metabolic disorder. There are no reports of an association between 
neonatal hyperglycaemia and gastroschisis.
Case presentation: This report presents preoperative and intraoperative management of blood sugar in a low birth 
weight Thai preterm neonate with gastroschisis and a diagnosis of neonatal hyperglycaemia. The patient underwent 
an emergency, multi‑staged, surgical repair under general anaesthesia.
Conclusion: Anaesthesiologists should be aware of possible perioperative dysglycaemic conditions in these patients. 
Proper timing of surgery and appropriate preanaesthetic preparation are necessary to reduce the morbidity and mor‑
tality related to hyperglycaemia and gastroschisis.
Consent: The patient’s guardian has given consent for the case report to be published.
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Background
Dysglycaemia frequently occurs in very low birth weight 
preterm infants. Deficiency of glycogen stores at birth 
and defective counter-regulatory hormone responses are 
common in prematurity, making hypoglycaemia a more 
frequent occurrence than hyperglycaemia [1]. The inci-
dence of neonatal hyperglycaemia has not been clearly 
reported because there is no consensus on its definition. 
Most reports have defined neonatal hyperglycaemia as 
blood glucose concentrations >7  mmol/L (>126  mg/dL) 
for term infants, and >8.3 mmol/L (>150 mg/dL) for pre-
term infants [1, 2].
Gastroschisis is a congenital abdominal wall defect 
which occurs in 1 in 15,000 live births. This condition 
rarely has associated abnormalities [3], and there is no 
previous report of gastroschisis with neonatal hyper-
glycaemia. Generally, infants with gastroschisis require 
emergency surgical correction in order to prevent further 
fluid loss and infection [3]. Nevertheless, the timing of 
the surgical correction of the gastroschisis in this par-
ticular case was somewhat controversial. This report 
demonstrates the challenge of decision-making by a mul-
tidisciplinary team that analysed the risks and benefits of 
promptly going to surgery versus waiting to optimize the 
patient’s condition.
Case report
Written, informed consent was obtained from the 
patient’s guardian for the publication of this case report.
A Thai male baby was born by elective caesarean sec-
tion at 34  weeks of gestation by a 19-year-old, primi-
gravida Thai female at a private hospital. The mother did 
not have any major diseases, and there was no family his-
tory of diabetes mellitus. No evidence of complications 
of pregnancy was found during the antenatal period. 
Gastroschisis was detected by prenatal ultrasonogra-
phy during routine screening. Bowel loops were seen 
herniating into the amniotic cavity, and they were float-
ing without any covering membrane. Dexamethasone (5 
mg intramuscularly, with 4 doses 12-hourly) was then 
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administered before pregnancy termination. The baby 
boy’s birth weight was 1590 g, appropriate for his gesta-
tional age. The Apgar scores at the 1st and the 5th min 
were 9 and 10, respectively. The baby was active, and no 
associated anomalies were detected.
The baby was shifted to the Neonatal Intensive Care 
Unit (NICU). The intestinal loops were enclosed in a ster-
ile plastic sheet and placed in midline. The blood sugar 
level was checked immediately, with a result of 114 mg/
dL (6.3 mmol/L). Six milliliters per hour (ml/h) of 10 % 
Dextrose and one-fifth normal saline (10 %D/N/5) were 
administered with a glucose infusion rate, or GIR, of 
6.28  mg/kg/min. A complete blood count and serum 
electrolyte test were performed, but the results were nor-
mal.Subsequently, the baby was transferred to a univer-
sity tertiary hospital for repair of the gastroschisis. Upon 
his arrival, the blood sugar level was checked in his 4th 
hour of life by point-of-care testing (POCT, the Lifescan 
SureStep Flexx Meter, Lifescan, Inc., United States). The 
result showed “high”, which was equivalent to a glucose 
concentration >600  mg/dL in the pertinent plasma. An 
analysis of the plasma glucose by a laboratory test was 
not able to be performed because of a difficult venipunc-
ture. However, laboratory tests did show negative find-
ings of urine ketone and urine sugar. The decrement of 
GIR was adjusted in order to decrease the blood glucose 
levels. The intravenous fluid was changed to 5 %D/N/5 to 
keep the GIR at 4–8 mg/kg/min. The POCT was repeated 
hourly, but the results still revealed “high” even though 
the GIR was further reduced to 1.65  mg/kg/min at the 
6th hour of life. Gastroschisis is considered to be a sur-
gical emergency requiring the closure or coverage of 
the abdominal contents after birth. A multi-disciplinary 
team, including paediatric surgeons, anaesthesiologists 
and neonatologists, were enrolled to discuss the risks and 
the benefits of delaying surgery. They were concerned 
about evaporation and heat loss. Stress and infection 
would also worsen the hyperglycaemic condition. The 
team finally decided to send the patient to the operative 
room because of the large abdominal wall defect that 
needed a sterile site and some special equipment. Mean-
while, fluid resuscitation was performed and POCT was 
rechecked.
In the operating room, standard monitoring was per-
formed. It included pre- and post-ductal oximetry, an 
electrocardiogram, non-invasive blood pressure, capnog-
raphy, temperature, POCT and urine output. A general 
anaesthesia utilising an endotracheal tube was inducted 
by administering thiopental and intubating with suc-
cinylcholine. The anaesthesia was maintained by using 
fentanyl, atracurium, isoflurane, air and oxygen. The 
intraoperative POCT sustained high during the 1st hour 
of the surgery. The intravenous regular insulin infusion 
was started at 0.06 units/kg/h, and the glucose infusion 
rate was reduced to 1.57 mg/kg/min in the 2nd hour. One 
hour after initiation of the regular insulin, the POCT 
reading of the baby’s blood sugar level was still immeas-
urably high. A constant, intravenous glucose infusion rate 
was maintained. Then, the regular insulin infusion dose 
was increased from 0.06 to 0.1 units/kg/h, and blood 
sugar level was checked.
The staged repair, utilising a protective silo place-
ment, lasted for 3 h. The patient remained intubated and 
received a regular insulin infusion dose of 0.1 units/kg/h 
while being transferred to the neonatal surgical ICU. His 
blood sugar level had a tendency to decrease at the 10th 
hour of life. The first measurable result by POCT was 
406 mg/dL, and the venous blood sugar confirmation at 
that time was 426 mg/dL. Then, 0.06 units/kg/h of intra-
venous regular insulin infusion was given for 4 h. The 
regular insulin was stopped at the 14th hour of life when 
the blood sugar result was 161 mg/dL. The blood sugar 
level, the insulin infusion and the intraoperative man-
agement are summarised at Table 1. Neither seizure nor 
convulsion was found during the perioperative period.
The baby was scheduled for a fascial closure on his 3rd 
day of life. The surgery was uneventful, and he was dis-
charged to home after 2  weeks of admission. His blood 
sugar level was in the normal range from his 14th hour 
of life until the hospital discharge, and he did not dem-
onstrate any hyperglycaemic episodes. During the long-
term follow-up at the 3rd, 8th, and 20th months of age, 
Table 1 Perioperative glucose management, point-of-care 
glucose results and venous blood glucose in the first 15 h











0 6.28 0 114 –
1 6.28 0 – –
2 6.28 0 – –
3 6.28 0 – –
4 6.28 0 High –
5 3.14 0 High –
6 1.65 0 High –
7 1.57 0.06 High –
8 1.57 0.1 High –
9 1.57 0.1 High –
10 1.57 0.06 406 426
11 1.57 0.06 326 –
12 1.57 0.06 305 –
13 1.57 0.06 263 –
14 1.57 0 161 –
15 1.57 0 70 –
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the child presented with normal growth and develop-
ment without any signs of metabolic syndrome or neuro-
logical problems.
Discussion
Gastroschisis is an emergency, surgical condition in pre-
term infants [4]. This case was unusual in that the patient 
presented with hyperglycaemia. The hyperglycaemic con-
dition could have arisen from a multitude of factors, e.g., 
stress induced hyperglycaemia, infection and iatrogenic 
intravenous glucose loading. The stress response to the 
surgery and the existing hyperglycaemia may cause perio-
perative ketoacidosis or hyperosmolar syndrome. How-
ever, delaying surgery results in ongoing hypovolaemia 
and an increased risk of sepsis, which can worsen glucose 
homeostasis and metabolic disorder [3]. As a result, mor-
bidity and mortality increase [2, 5]. A multi-disciplinary 
team, including surgeons, paediatricians and anaesthesi-
ologists, should correct the underlying causes immedi-
ately. In general, stress correction is usually sufficient to 
improve the hyperglycaemic condition [6]. Important, 
significant factors for this patient were the timing of the 
surgery and strategies for perioperative glycaemic control.
This patient met the diagnostic definition of transient 
neonatal hyperglycaemia [1, 2, 7]. The first management-
step for hyperglycaemic patients is to confirm the diag-
nosis and search for possible causes. The probable causes 
of hyperglycaemia in this case were a counter-regulatory 
response to stress, gastroschisis and immature organ 
function.Other causes of neonatal hyperglycaemia could 
be the combination of a decreased amount of insulin pro-
duction, inadequate insulin response to perinatal stress, 
drugs (steroid, Beta-2 agonist, phenytoin, theophylline), 
genetic and the amount of glucose infusion [1, 2, 6, 8]. A 
maternal dexamethasone injection for foetal lung matu-
ration may result in high blood sugar levels in the preg-
nant mothers [9]. No previous study had revealed the 
relationship between a maternal dexamethasone injec-
tion and the neonatal blood glucose levels. Genetic fac-
tors such as chromosomal abnormalities in the imprinted 
region of chromosome 6q24, or mutations in genes 
KCNJ11 (Kir6.2) or ABCC8 (SUR1), could be commonly 
found in patients with transient neonatal diabetes [7, 
10].However, genetic testing of the patient was not done 
because the hyperglycaemia was transient.
Concerning the morbidity and mortality of this condi-
tion, e.g., osmotic diuresis, sepsis, and a longer hospital 
stay, most institutions recommend starting treatment [2, 
5]. Treatment options could be doing nothing, reducing 
the amount of glucose given, treating the patient with 
insulin, or all of the above alternatives [1, 2, 8, 11]. Never-
theless, there is currently no scientifically-supported ref-
erence value and standard guideline for the management 
of a neonatal hyperglycaemic condition. A goal for the 
paediatric, intra-operative blood glucose range is still 
being debated.In the case of paediatric, cardiac-surgery 
patients, it has been suggested that maintaining a glucose 
level of less than 7.8 mmol/L (140 mg/dL) would reduce 
morbidity, mortality and improve patient outcomes [12]. 
Due to the persistently high blood sugar level of this 
infant, a regular insulin infusion was given to facilitate 
glucose intake after a period of reduced glucose intake 
[13]. Many institutions have created and developed clini-
cal practice guidelines for regular insulin infusion therapy 
for neonates. The starting dose of the regular insulin var-
ies from 0.02 to 0.1 units/kg/h. Subsequently, the regular 
insulin infusion rate should be adjusted hourly by 0.01–
0.02 units/kg/h, according to the patients’ responses. 
Regular blood sugar monitoring should be done while 
administering the insulin infusion [13, 14].
As for this patient, the staged-repair operation was 
done while the glucose intake and regular insulin infu-
sion were adjusted. The starting dose of the regular 
insulin infusion was 0.06 units/kg/h, and the rate was 
increased to 0.1 units/kg/h in the next hour. Insulin dis-
continuation was based on a recommendation to stop 
insulin infusion in a neonate if the blood glucose level is 
less than 200 mg/dL [14]. Frequent blood sugar sampling 
should be done even after no insulin is infused. Because 
of poor organ function, the half-life of insulin could be 
prolonged and result in late hypoglycaemia.In this case, a 
low-normal blood sugar level was found in the 2nd hour 
after discontinuation of the intravenous regular insulin.
Insulin availability depends on several factors, such as 
the tube material, the length of the insulin tubing and 
the timing of the insulin usage. In this case, insulin-tube 
priming with 5 IU/ml of regular insulin solution was per-
formed for 20 min both to improve the insulin bioavail-
ability and to reduce insulin absorption by the tubing 
material. We could not measure the amount of insulin 
absorption by the insulin tube but hypothesize that insu-
lin absorption via the tubing resulted in a delayed insulin 
response. Further studies are needed to find an efficient 
way of handling intravenous insulin infusions, includ-
ing the proper tube length and size, the insulin volume 
needed for tube priming, and the time for tube prim-
ing [14, 15]. Lowering of the blood sugar could then be 
achieved effectively by increasing both the dose of the 
insulin infusion and its bioavailability.
In retrospect, even though gastroschisis is a surgical 
emergency, a general anaesthesia and operative-theatre 
procedure may not be necessary on the very 1st day. To 
avoid intra-operative stress arising from the anaesthesia 
and surgery in this severe hyperglycaemic-infant, con-
sideration could have been given to performing the silo 
bedside.
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Conclusion
To date, there are no reports of an association between 
neonatal hyperglycaemia and gastroschisis. Anaesthesi-
ologists should therefore be aware of the possible, perio-
perative, dysglycaemic conditions of these patients. The 
proper timing of surgery and appropriate, pre-anaesthetic 
preparation are necessary to reduce the morbidity and 
mortality related to hyperglycaemia and gastroschisis.
Consent
Written informed consent was obtained from the 
patient’s legal guardians for publication of this Case 
Report and any accompanying images.
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